Antibe Therapeutics Inc
F:4B70
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Antibe Therapeutics Inc
F:4B70
|
CA |
|
FalconStor Software Inc
OTC:FALC
|
US |
|
F
|
Faran Sugar Mills Ltd
KAR:FRSM
|
PK |
|
C
|
Clean Seas Seafood Ltd
F:C7S
|
AU |
|
Rio Silver Inc
OTC:RYOOD
|
CA |
|
F
|
Feper SA
XBSE:FEP
|
RO |
|
Royal Road Minerals Ltd
F:RLU
|
JE |
|
S
|
Smart Sand Inc
F:1SD
|
US |
|
R
|
Real Good Food PLC
XBER:MLM
|
UK |
|
C
|
ChargePanel AB (publ)
STO:CHARGE
|
SE |
|
SDX Energy PLC
F:3KX
|
UK |
|
Bigben Interactive SA
PAR:BIG
|
FR |
|
Chiba Bank Ltd
OTC:CHBAF
|
JP |
|
Vow Green Metals AS
F:9G5
|
NO |
|
B
|
Baloise Holding AG
XMUN:BLON
|
CH |
|
A
|
Aurcrest Gold Inc
F:TM8A
|
CA |
|
A
|
Amaero International Ltd
OTC:AMROF
|
AU |
|
Seiren Co Ltd
OTC:SERNF
|
JP |
|
R
|
Repsol SA
XMUN:REP
|
ES |
|
Core One Labs Inc
F:LD6
|
CA |
|
C
|
Clinica Baviera SA
SWB:D9Z
|
ES |
|
P
|
Pensana PLC
DUS:48W
|
UK |
|
V
|
Virtual Ed Link Inc
OTC:VRED
|
US |
|
B
|
BluGlass Ltd
OTC:BUGLF
|
AU |
Bankruptcy Probability
Antibe Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Antibe Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CA |
|
Antibe Therapeutics Inc
TSX:ATE
|
4.7m CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.2T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
652.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
333.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
241.6B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
186.9B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
243.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
256.4B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Antibe Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Antibe Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.
